ENDRA Life Sciences (NDRA) Return on Sales (2016 - 2018)

ENDRA Life Sciences (NDRA) has 3 years of Return on Sales data on file, last reported at 15.87% in Q4 2018.

• Return on Sales for Q4 2018 came in at 15.87%, down 1252.0% year-over-year; the trailing twelve-month figure through Dec 2018 was 15.87% (down 1571.0% YoY), and the FY2018 annual result was 15.87%, down 1571.0% from the prior year.
• Return on Sales declined to 15.87% in Q4 2018 per NDRA's latest filing, from 7.47% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q4 2016 and troughed at 15.87% in Q4 2018.
• A 3-year average of 3.98% and a median of 1.81% in 2018 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 1 bps in 2018 and fell as far as 1252 bps in 2018.
• A 3-year view of Return on Sales shows it stood at 0.01% in 2016, then tumbled by 24971 bps to 3.35% in 2017, then plunged by 374 bps to 15.87% in 2018.
• Business Quant data shows NDRA's Return on Sales at 15.87% in Q4 2018, 7.47% in Q3 2018, and 0.26% in Q2 2018.